Recently Featured

Sun recalls US chemotherapy batch, citing glass particle contamination concerns

May 29, 2026
Generics juggernaut Sun Pharma is recalling a specific lot of a chemotherapy drug in the United States due to concerns over glass particle contamination. This action highlights a recurring issue within the pharmaceutical industry, where particulate contamination has increasingly become a focus for regulatory bodies such as the FDA. The recall not only raises questions…

Bora Group Acquires MacroGenics’ CDMO Operations for Up to $127.5 Million

May 29, 2026
Taiwan’s Bora Group has announced its acquisition of the contract development and manufacturing organization (CDMO) operations from Maryland-based MacroGenics for a total consideration of up to $127.5 million. This strategic move reflects Bora’s commitment to expanding its capabilities in the biopharmaceutical manufacturing sector, enhancing its portfolio and operational footprint. The acquisition comes at a time…

Johns Hopkins Study Reveals Mechanisms of Receptor Transport in Neurons via Transcytosis

May 29, 2026
Researchers at Johns Hopkins University have successfully visualized the transport of the nerve growth factor receptor TrkA within neurons through a process known as transcytosis. This imaging study sheds light on how this unconventional mechanism facilitates neuronal function and connectivity in mice, providing critical insights into receptor trafficking that could influence future therapeutic strategies. In…

Hantavirus risk remains low, CDC says, citing its ‘playbook’ response

May 29, 2026
Two doctors with the Centers for Disease Control and Prevention (CDC) stated on Wednesday that the risk to Americans from the hantavirus outbreak remains low, emphasizing that the agency is “engaged at every step.” This assurance comes amid growing concerns about the virus, which has been linked to severe respiratory illness and is typically transmitted…

Ongoing Cases